ロード中...
BCL2 as a Subtype-Specific Prognostic Marker for Breast Cancer
PURPOSE: B-cell lymphoma 2 (BCL2) is an antiapoptosis protein and an important clinical breast cancer prognostic marker. As the role of BCL2 is dependent on the estrogen receptor (ER) status, this effect might differ according to molecular subtypes. The aim of this study was to evaluate the relation...
保存先:
| 出版年: | J Breast Cancer |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Korean Breast Cancer Society
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5053309/ https://ncbi.nlm.nih.gov/pubmed/27721874 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4048/jbc.2016.19.3.252 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|